Engineering Periosteum to Promote Bone Graft Healing

Catherine Rategan

Failure rates are sure to weigh on the minds of patients in need of a bone graft. Studies have found that half of all allografts following tumor resection fail in the first 5 years. At 10 years, that statistic rises to 60 percent. Moreover, 75 percent of nonfatal war wounds are injuries of the extremities that involve infected critical-size defects. Danielle S. W. Benoit, PhD Biological boosters Dr.

Human Allograft Bone Processing and Safety

Ross M. Wilkins, MD; Steven Gitelis, MD; Robert A. Hart, MD; Allen E. Gross, MD, FRCSC, Prof

During the past 50 years, the use of human bone allograft has been increasing, with the most dramatic increases occurring during the past decade. An estimated 1 million allografts will be used in the United States in 2013.

Young Investigator Recognized for Research in Mechanics of Bone Healing

Terry Stanton

Elise Feng-i Morgan, PhD AAOS Now: Much of your work centers on distraction osteogenesis (DO). How is this process applied and managed clinically? Dr. Morgan: DO is a procedure for lengthening and sometimes reshaping a bone. It is used both clinically and as a research tool. The basic idea, in the simplest fashion, is that a cut is made across the bone, and the two halves are stabilized with hardware.

CPGs In Development

The AAOS Clinical Practice Guidelines (CPG) unit is currently working on the following CPGs: Treatment of Osteoarthritis of the Knee (OAK) Early Detection and Management of Pediatric Developmental Dysplasia of the Hip (DDH) Management of Hip Fractures in Elderly Patients (Hip Fx) Anterior Cruciate Ligament Injuries (ACL) Surgical Management of Osteoarthritis of the Knee (SMOAK) CPGs are developed using a rigorous, standardized process, corresponding to the In